biomarker-trends-header.png

Chart of the Week: Phase 3 LOA Vs Biomarker Coverage Percent

This week’s Chart of the Week demonstrates recent research on the correlation between the Biomarker Coverage Percent in a company's pipeline and the Company's Phase 3 Likelihood of Approval. This chart depicts how as a company increases their number of trials utilizing biomarkers, they will also ...

Chart of the Week: Phase 3 LOA Vs Precision Medicine Score

This week’s Chart of the Week attempts to communicate the correlation between a Company's Precision Medicine Score and the Company's Phase 3 Likelihood of Approval (LOA). This chart depicts how as a company increases their Precision Medicine Score, they will also see an increase in their likelihood ...

Chart of the Week: Missed Biomarker Information Without Comprehensive Synonyms

This week’s Chart of the Week attempts to communicate recent research on the percent of results you are missing in your clinical information searches (e.g. pubmed, clinicaltrials.gov, etc) without utilizing  target and synonym technologies like in BiomarkerBase. This chart depicts how many relevant ...

Chart of the Week: Percent Decrease in Curation Time with BiomarkerBase

This week’s Chart of the Week communicates recent research on the irrelevant results found through manual review of literature versus results found through a combination of human and machine curation.

Chart of the Week: Literature Review: Time Spent on Irrelevant Results

This week’s Chart of the Week attempts to communicate recent research on pure manual review of literature versus a combination of human and machine curation.

   

December

Webinar: 

Pharmacovigilance and Safety Biomarkers

RECORDING
New Call-to-action
FREE REPORT

Subscribe for Updates

Download our Free IVD Trends Report